PCRX Pacira BioSciences, Inc.
Nasdaq · SEC CIK 1396814 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.53M 13 sales by 5 insiders
- Filings on record
- 191 since 2021-07-06, latest 2026-08-18 17:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cross Shawn | CFO | — | $1.52M |
| WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| RIKER LAUREN | SVP, Fin | — | $261.3K |
| SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| Froimson Mark | Dir | — | $10.9K |
| BIGAL MARCELO | Dir | — | — |
| Young Alethia | Dir | — | — |
| Teehan Brendan | Chief Commercial Off | — | — |
| Lee Frank D. | CEO, Dir | — | — |
| CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 236
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-12 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $28.72 | -3,970 | 38.1K | -9% | -$114.0K | |
| 2024-06-13 | 2024-06-12 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | A - Grant | $0.00 | +54.3K | 110.4K | +97% | $0 | |
| 2024-06-13 | 2024-06-13 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $28.38 | -7,452 | 102.9K | -7% | -$211.5K | |
| D | 2024-06-13 | 2024-06-12 | PCRX | YANG MICHAEL J. | Dir | A - Grant | $0.00 | +5,230 | 5,230 | New | $0 |
| 2024-06-05 | 2024-06-03 | PCRX | Reinhart Charles A. III | CFO | F - Tax | $30.89 | -2,979 | 39.6K | -7% | -$92.0K | |
| 2024-06-05 | 2024-06-03 | PCRX | GAUGLER DARYL | COO | F - Tax | $30.89 | -2,754 | 62.7K | -4% | -$85.1K | |
| 2024-06-05 | 2024-06-03 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $30.89 | -1,843 | 20.7K | -8% | -$56.9K | |
| 2024-06-05 | 2024-06-03 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $30.89 | -3,011 | 56.1K | -5% | -$93.0K | |
| 2024-06-05 | 2024-06-03 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $30.89 | -1,615 | 49.6K | -3% | -$49.9K | |
| M | 2024-03-08 | 2024-03-06+ | PCRX | PACE GARY W | Dir | S - Sale | $30.64 | -119.3K | 22.1K | -84% | -$3.66M |
| 2024-02-07 | 2024-02-05 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | A - Grant | $0.00 | +33.7K | 59.1K | +133% | $0 | |
| 2024-02-07 | 2024-02-05 | PCRX | GAUGLER DARYL | COO | A - Grant | $0.00 | +33.7K | 65.5K | +106% | $0 | |
| D | 2024-01-04 | 2024-01-02 | PCRX | Lee Frank D. | CEO, Dir | A - Grant | $0.00 | +99.5K | 99.5K | New | $0 |
| D | 2024-01-04 | 2024-01-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $0.00 | +5,000 | 51.2K | +11% | $0 |
| 2024-01-04 | 2024-01-02 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $32.00 | -159 | 22.5K | -0.7% | -$5,088 | |
| 2023-08-04 | 2023-08-02 | PCRX | WINSTON ROY | Chief Medical Off | S - Sale | $34.88 | -509 | 52.4K | -1.0% | -$17.8K | |
| 2023-07-07 | 2023-07-05 | PCRX | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.91 | -643 | 22.7K | -3% | -$25.0K | |
| D | 2023-06-16 | 2023-06-14 | PCRX | PACE GARY W | Dir | A - Grant | $0.00 | +1,775 | 141.4K | +1% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Williams Kristen Marie | Chief Administrative Off | A - Grant | $0.00 | +10.9K | 31.8K | +52% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Williams Kristen Marie | Chief Administrative Off | S - Sale | $37.03 | -6,467 | 25.4K | -20% | -$239.5K |
| D | 2023-06-16 | 2023-06-14 | PCRX | CHRISTIE CHRISTOPHER | Dir | A - Grant | $0.00 | +1,775 | 5,261 | +51% | $0 |
| DM | 2023-06-16 | 2023-06-14 | PCRX | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.42 | -6,366 | 22.7K | -22% | -$244.6K |
| D | 2023-06-16 | 2023-06-14 | PCRX | Riker Lauren Bullaro | SVP, Fin | A - Grant | $0.00 | +10.0K | 29.1K | +52% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Reinhart Charles A. III | CFO | A - Grant | $0.00 | +9,000 | 42.6K | +27% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Brege Laura | Dir | A - Grant | $0.00 | +1,775 | 11.3K | +19% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Froimson Mark | Dir | A - Grant | $0.00 | +1,775 | 7,843 | +29% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | STACK DAVID M | CEO, COB, Dir | A - Grant | $0.00 | +32.7K | 186.5K | +21% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | WINSTON ROY | Chief Medical Off | A - Grant | $0.00 | +10.9K | 52.3K | +26% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | HASTINGS PAUL J | Dir | A - Grant | $0.00 | +1,775 | 8,374 | +27% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | GAUGLER DARYL | COO | A - Grant | $0.00 | +10.0K | 31.5K | +46% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +1,775 | 19.7K | +10% | $0 |
| D | 2023-06-12 | 2023-06-08 | PCRX | Kronenfeld Mark A. | Dir | M - OptEx | $29.90 | +15.0K | 32.9K | +84% | +$448.5K |
| D | 2023-06-12 | 2023-06-08 | PCRX | Kronenfeld Mark A. | Dir | S - Sale+OE | $37.04 | -15.0K | 17.9K | -46% | -$555.6K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale | $38.42 | -2,153 | 30.3K | -7% | -$82.7K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Ellis Ronald J. Jr. | Chief Strategy Off | S - Sale | $38.42 | -2,276 | 32.1K | -7% | -$87.4K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | SLONIN JONATHAN | Chief Clinical Off | S - Sale | $38.42 | -961 | 36.3K | -3% | -$36.9K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | McLoughlin Dennis | Chief Customer Off | S - Sale | $38.42 | -2,071 | 39.2K | -5% | -$79.6K |
| 2023-06-07 | 2023-06-05 | PCRX | HASTINGS PAUL J | Dir | S - Sale | $38.34 | -580 | 6,599 | -8% | -$22.2K | |
| M | 2023-06-07 | 2023-06-06+ | PCRX | WINSTON ROY | Chief Medical Off | S - Sale | $38.42 | -3,636 | 43.2K | -8% | -$139.7K |
| M | 2023-06-07 | 2023-06-05+ | PCRX | GAUGLER DARYL | COO | S - Sale | $38.52 | -3,052 | 23.6K | -11% | -$117.6K |
| 2023-06-07 | 2023-06-05 | PCRX | Brege Laura | Dir | S - Sale | $38.74 | -600 | 9,547 | -6% | -$23.2K | |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Reinhart Charles A. III | CFO | S - Sale | $38.40 | -2,607 | 33.6K | -7% | -$100.1K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | STACK DAVID M | CEO, COB, Dir | S - Sale | $38.42 | -10.4K | 159.1K | -6% | -$398.9K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.42 | -1,207 | 19.7K | -6% | -$46.4K |
| M | 2023-06-07 | 2023-06-05+ | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | S - Sale | $38.46 | -6,788 | 12.9K | -35% | -$261.1K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Williams Kristen Marie | Chief Administrative Off | S - Sale | $38.42 | -2,658 | 20.9K | -11% | -$102.1K |
| D | 2023-06-02 | 2023-05-31 | PCRX | GAUGLER DARYL | COO | M - OptEx | $34.00 | +2,500 | 26.9K | +10% | +$85.0K |
| D | 2023-06-02 | 2023-05-31 | PCRX | GAUGLER DARYL | COO | S - Sale+OE | $39.08 | -2,500 | 24.6K | -9% | -$97.7K |
| D | 2023-05-17 | 2023-05-15 | PCRX | HASTINGS PAUL J | Dir | M - OptEx | $29.90 | +7,000 | 14.2K | +98% | +$209.3K |
| D | 2023-05-17 | 2023-05-15 | PCRX | HASTINGS PAUL J | Dir | S - Sale+OE | $41.85 | -7,000 | 7,179 | -49% | -$292.9K |
| D | 2023-05-15 | 2023-05-11 | PCRX | PACE GARY W | Dir | M - OptEx | $29.90 | +7,000 | 144.7K | +5% | +$209.3K |
| D | 2023-05-15 | 2023-05-11 | PCRX | PACE GARY W | Dir | S - Sale+OE | $41.78 | -5,015 | 139.7K | -3% | -$209.5K |
| D | 2023-04-05 | 2023-04-03 | PCRX | Brege Laura | Dir | M - OptEx | $29.90 | +7,000 | 17.1K | +69% | +$209.3K |
| D | 2023-04-05 | 2023-04-03 | PCRX | Brege Laura | Dir | S - Sale+OE | $40.72 | -7,000 | 10.1K | -41% | -$285.0K |
| M | 2023-01-06 | 2023-01-04+ | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | S - Sale | $38.49 | -704 | 19.4K | -3% | -$27.1K |
| 2022-10-11 | 2022-10-07 | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale | $58.00 | -1,380 | 31.4K | -4% | -$80.0K | |
| 2022-08-05 | 2022-08-03 | PCRX | SLONIN JONATHAN | Chief Clinical Off | S - Sale | $55.70 | -308 | 37.1K | -0.8% | -$17.2K | |
| 2022-08-05 | 2022-08-03 | PCRX | WINSTON ROY | Chief Medical Off | S - Sale | $55.70 | -476 | 45.0K | -1% | -$26.5K | |
| 2022-07-13 | 2022-07-11 | PCRX | HASTINGS PAUL J | Dir | S - Sale | $56.95 | -533 | 7,179 | -7% | -$30.4K | |
| 2022-07-07 | 2022-07-05 | PCRX | SLONIN JONATHAN | Chief Clinical Off | S - Sale | $57.19 | -924 | 37.4K | -2% | -$52.8K | |
| D | 2022-06-16 | 2022-06-14 | PCRX | LARANJEIRA CHARLES ANTHONY | Chief Technical Off | M - OptEx | $38.35 | +6,000 | 41.8K | +17% | +$230.1K |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale | $61.66 | -5,250 | 24.4K | -18% | -$323.7K |
| D | 2022-06-08 | 2022-06-08 | PCRX | REINHARDT MAX | Pres, Rest of World | A - Grant | $0.00 | +7,950 | 32.2K | +33% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Brege Laura | Dir | A - Grant | $0.00 | +1,160 | 10.1K | +13% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | PACE GARY W | Dir | A - Grant | $0.00 | +1,160 | 137.7K | +0.8% | $0 |
| DM | 2022-06-08 | 2022-06-08 | PCRX | GAUGLER DARYL | COO | A - Grant | $0.00 | +12.9K | 19.4K | +199% | $0 |
| D | 2022-06-08 | 2022-06-06 | PCRX | GAUGLER DARYL | COO | S - Sale | $61.37 | -1,106 | 11.5K | -9% | -$67.9K |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | Williams Kristen Marie | Chief Administrative Off | S - Sale | $60.37 | -8,618 | 13.7K | -39% | -$520.2K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Williams Kristen Marie | Chief Administrative Off | A - Grant | $0.00 | +9,900 | 23.6K | +73% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Reinhart Charles A. III | CFO | A - Grant | $0.00 | +7,950 | 36.2K | +28% | $0 |
| D | 2022-06-08 | 2022-06-06 | PCRX | Reinhart Charles A. III | CFO | S - Sale | $61.37 | -2,516 | 28.3K | -8% | -$154.4K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Greenstreet Yvonne | Dir | A - Grant | $0.00 | +1,160 | 13.2K | +10% | $0 |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | LARANJEIRA CHARLES ANTHONY | Chief Technical Off | S - Sale | $60.38 | -7,750 | 25.9K | -23% | -$467.9K |
| D | 2022-06-08 | 2022-06-08 | PCRX | LARANJEIRA CHARLES ANTHONY | Chief Technical Off | A - Grant | $0.00 | +9,900 | 35.8K | +38% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Froimson Mark | Dir | A - Grant | $0.00 | +1,160 | 6,068 | +24% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | SLONIN JONATHAN | Chief Clinical Off | A - Grant | $0.00 | +9,900 | 38.1K | +35% | $0 |
| D | 2022-06-08 | 2022-06-06 | PCRX | SLONIN JONATHAN | Chief Clinical Off | S - Sale | $61.37 | -362 | 28.2K | -1% | -$22.2K |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | S - Sale | $60.78 | -5,550 | 13.8K | -29% | -$337.4K |
| D | 2022-06-08 | 2022-06-08 | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | A - Grant | $0.00 | +7,950 | 19.9K | +66% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +1,160 | 17.9K | +7% | $0 |
| D | 2022-06-08 | 2022-06-06 | PCRX | Riker Lauren Bullaro | SVP, Fin | S - Sale | $61.37 | -1,150 | 14.0K | -8% | -$70.6K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Riker Lauren Bullaro | SVP, Fin | A - Grant | $0.00 | +5,850 | 19.9K | +42% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | CHRISTIE CHRISTOPHER | Dir | A - Grant | $0.00 | +1,160 | 3,486 | +50% | $0 |
| DM | 2022-06-08 | 2022-06-06 | PCRX | WINSTON ROY | Chief Medical Off | S - Sale+OE | $61.39 | -17.5K | 44.4K | -28% | -$1.08M |
| D | 2022-06-08 | 2022-06-06 | PCRX | WINSTON ROY | Chief Medical Off | M - OptEx | $34.38 | +6,250 | 50.6K | +14% | +$214.9K |
| D | 2022-06-08 | 2022-06-08 | PCRX | WINSTON ROY | Chief Medical Off | A - Grant | $0.00 | +9,900 | 45.1K | +28% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | McLoughlin Dennis | Chief Customer Off | A - Grant | $0.00 | +7,950 | 39.8K | +25% | $0 |
| D | 2022-06-08 | 2022-06-06 | PCRX | McLoughlin Dennis | Chief Customer Off | S - Sale | $61.37 | -2,140 | 31.8K | -6% | -$131.3K |
| D | 2022-06-08 | 2022-06-08 | PCRX | HASTINGS PAUL J | Dir | A - Grant | $0.00 | +1,160 | 7,712 | +18% | $0 |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | STACK DAVID M | CEO, COB, Dir | S - Sale | $60.56 | -25.8K | 144.0K | -15% | -$1.56M |
| D | 2022-06-08 | 2022-06-08 | PCRX | STACK DAVID M | CEO, COB, Dir | A - Grant | $0.00 | +21.5K | 163.8K | +15% | $0 |
| D | 2022-05-25 | 2022-05-23 | PCRX | SLONIN JONATHAN | Chief Clinical Off | M - OptEx | $52.37 | +2,000 | 28.6K | +8% | +$104.7K |
| 2022-05-11 | 2022-05-09 | PCRX | Froimson Mark | Dir | S - Sale | $59.37 | -1,000 | 4,908 | -17% | -$59.4K | |
| D | 2022-05-02 | 2022-04-28 | PCRX | STACK DAVID M | CEO, COB, Dir | M - OptEx | $10.81 | +22.5K | 168.0K | +15% | +$243.2K |
| D | 2022-04-25 | 2022-04-21 | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale+OE | $73.25 | -9,824 | 29.6K | -25% | -$719.6K |
| D | 2022-04-25 | 2022-04-21 | PCRX | REINHARDT MAX | Pres, Rest of World | M - OptEx | $42.54 | +12.5K | 39.5K | +46% | +$531.8K |
| DM | 2022-04-20 | 2022-04-18+ | PCRX | REINHARDT MAX | Pres, Rest of World | M - OptEx | $42.54 | +37.5K | 30.0K | New | +$1.60M |
| DM | 2022-04-20 | 2022-04-18+ | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale+OE | $73.27 | -28.0K | 27.0K | -51% | -$2.05M |
| DM | 2022-04-08 | 2022-04-06 | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | M - OptEx | $40.77 | +22.5K | 40.0K | +128% | +$917.4K |
| DM | 2022-04-08 | 2022-04-06 | PCRX | MOLLOY ANTHONY | Chief Lgl, Compliance Off | S - Sale+OE | $76.42 | -22.5K | 24.0K | -48% | -$1.72M |
Purchase Sale Sale after option exercise All abbreviations